TEHP Stock Overview
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Avid Bioservices, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.15 |
| 52 Week High | US$17.90 |
| 52 Week Low | US$4.12 |
| Beta | 1.62 |
| 1 Month Change | -2.38% |
| 3 Month Change | 2.50% |
| 1 Year Change | -65.64% |
| 3 Year Change | -64.86% |
| 5 Year Change | 56.57% |
| Change since IPO | -87.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| TEHP | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | -2.4% | -5.1% | -2.0% |
| 1Y | -65.6% | -21.1% | -0.3% |
Return vs Industry: TEHP underperformed the German Biotechs industry which returned -21.1% over the past year.
Return vs Market: TEHP underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| TEHP volatility | |
|---|---|
| TEHP Average Weekly Movement | 13.6% |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TEHP has not had significant price volatility in the past 3 months.
Volatility Over Time: TEHP's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 365 | Nick Green | www.avidbio.com |
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization.
Avid Bioservices, Inc. Fundamentals Summary
| TEHP fundamental statistics | |
|---|---|
| Market cap | €379.37m |
| Earnings (TTM) | -€10.75m |
| Revenue (TTM) | €132.31m |
2.9x
P/S Ratio-35.4x
P/E RatioIs TEHP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TEHP income statement (TTM) | |
|---|---|
| Revenue | US$140.94m |
| Cost of Revenue | US$123.29m |
| Gross Profit | US$17.65m |
| Other Expenses | US$29.10m |
| Earnings | -US$11.45m |
Last Reported Earnings
Oct 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | 12.52% |
| Net Profit Margin | -8.12% |
| Debt/Equity Ratio | 76.8% |
How did TEHP perform over the long term?
See historical performance and comparison